Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain

NCT07318688 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: HMI-115
DRUG: Placebo

Sponsor

Hope Medicine (Nanjing) Co., Ltd